Hoa H. Le

1.6k total citations
43 papers, 1.2k citations indexed

About

Hoa H. Le is a scholar working on Pathology and Forensic Medicine, Hematology and Psychiatry and Mental health. According to data from OpenAlex, Hoa H. Le has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Hematology and 7 papers in Psychiatry and Mental health. Recurrent topics in Hoa H. Le's work include Multiple Sclerosis Research Studies (11 papers), Multiple Myeloma Research and Treatments (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers). Hoa H. Le is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Multiple Myeloma Research and Treatments (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers). Hoa H. Le collaborates with scholars based in United States, Netherlands and Canada. Hoa H. Le's co-authors include Scott M. Belcher, Jason P. Chua, Emily M. Carlson, Attila Zsarnovszky, Eric L. Kendig, Hongsheng Wang, Maarten J. Postma, Paul Hodgkins, Jalpa A. Doshi and Jennifer Kahle and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hoa H. Le

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hoa H. Le United States	13	542	215	169	167	115	43	1.2k
Ana Laura Calderón‐Garcidueñas Mexico	19	868 1.6×	124 0.6×	254 1.5×	225 1.3×	131 1.1×	72	1.8k
Lucie Kolátorová Czechia	21	551 1.0×	136 0.6×	173 1.0×	150 0.9×	29 0.3×	51	1.2k
Eric R. Hugo United States	21	722 1.3×	179 0.8×	456 2.7×	131 0.8×	83 0.7×	30	2.0k
René Bérubé Canada	17	519 1.0×	340 1.6×	200 1.2×	135 0.8×	99 0.9×	22	1.5k
Joško Osredkar Slovenia	22	365 0.7×	120 0.6×	411 2.4×	93 0.6×	99 0.9×	78	1.7k
Jana Vítků Czechia	20	594 1.1×	115 0.5×	147 0.9×	165 1.0×	22 0.2×	40	1.2k
Ellen V.S. Hessel Netherlands	17	332 0.6×	84 0.4×	311 1.8×	122 0.7×	134 1.2×	43	1.1k
Claudia Pivonello Italy	27	395 0.7×	109 0.5×	387 2.3×	73 0.4×	50 0.4×	81	2.4k
Maria Skaalum Petersen Faroe Islands	24	535 1.0×	77 0.4×	154 0.9×	36 0.2×	89 0.8×	84	1.9k
Dominik Rachoń Poland	26	566 1.0×	348 1.6×	384 2.3×	186 1.1×	142 1.2×	75	2.2k

Countries citing papers authored by Hoa H. Le

Since Specialization

Citations

This map shows the geographic impact of Hoa H. Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoa H. Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoa H. Le more than expected).

Fields of papers citing papers by Hoa H. Le

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoa H. Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoa H. Le. The network helps show where Hoa H. Le may publish in the future.

Co-authorship network of co-authors of Hoa H. Le

This figure shows the co-authorship network connecting the top 25 collaborators of Hoa H. Le. A scholar is included among the top collaborators of Hoa H. Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoa H. Le. Hoa H. Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zivadinov, Robert, Hoa H. Le, Alexander Keenan, & Susan Jill Stocks. (2025). A systematic literature review of the association between global brain atrophy and the Expanded Disability Status Scale score in people with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 18. 4233584769–4233584769. 1 indexed citations

Sankar, K. Nathan, et al.. (2025). Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States. Advances in Therapy. 43(1). 214–230.

Zivadinov, Robert, Alexander Keenan, Hoa H. Le, et al.. (2024). Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies. BMC Neurology. 24(1). 378–378. 2 indexed citations

Neparidze, Natalia, et al.. (2024). Patient Perspectives on Social and Identity Factors Affecting Multiple Myeloma Care: Barriers and Opportunities. Healthcare. 12(16). 1587–1587. 1 indexed citations

Neparidze, Natalia, et al.. (2024). Impact of Social Needs and Identity Experiences on the Burden of Illness in Patients with Multiple Myeloma: A Mixed-Methods Study. Healthcare. 12(16). 1660–1660. 1 indexed citations

Le, Hoa H., et al.. (2024). A systematic literature review of the measurement of patient-reported fatigue in studies of disease modifying therapies for multiple sclerosis. Multiple Sclerosis and Related Disorders. 91. 105846–105846. 2 indexed citations

Neparidze, Natalia, et al.. (2024). Impact of Social Needs and Identity Experiences on the Burden of Illness for Patients with Multiple Myeloma: A Mixed-Methods Study. Clinical Lymphoma Myeloma & Leukemia. 24. S238–S238. 1 indexed citations

Keenan, Alexander, Chiara Whichello, Hoa H. Le, et al.. (2024). Clinicians’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment. PharmacoEconomics - Open. 8(6). 857–867. 1 indexed citations

Mian, Hira, et al.. (2023). Real-World Treatment Patterns and Clinical Outcomes Among Triple-Class Exposed and B-Cell Maturation Antigen (BCMA) Exposed Multiple Myeloma Patients. Blood. 142(Supplement 1). 542–542.

10.

Salter, Amber, Alexander Keenan, Hoa H. Le, et al.. (2023). Severity and worsening of fatigue among individuals with multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(2). 3100530279–3100530279. 6 indexed citations

11.

Neparidze, Natalia, et al.. (2023). A Mixed Methods Study to Describe the Relationship between Burden of Illness, Social Needs, and Identity Experiences Among Patients with Multiple Myeloma. Blood. 142(Supplement 1). 7353–7353. 1 indexed citations

12.

Leist, Thomas, et al.. (2023). A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy. Multiple Sclerosis and Related Disorders. 78. 104917–104917. 1 indexed citations

13.

Le, Hoa H., et al.. (2022). A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study. Multiple Sclerosis and Related Disorders. 59. 103637–103637. 5 indexed citations

14.

Denee, Tom, John Waller, Tom Bailey, et al.. (2020). A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom. Current Medical Research and Opinion. 37(2). 311–319. 6 indexed citations

15.

Le, Hoa H., et al.. (2016). Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada. Journal of Medical Economics. 19(6). 557–567. 9 indexed citations

16.

Stevanović, Jelena, et al.. (2014). Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands. PLoS ONE. 9(8). e103974–e103974. 29 indexed citations

17.

Connolly, Mark P., et al.. (2014). The burden of unintended pregnancies in Brazil: a social and public health system cost analysis. International Journal of Women s Health. 6. 663–663. 42 indexed citations

18.

Le, Hoa H., Paul Hodgkins, Maarten J. Postma, et al.. (2013). Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. European Child & Adolescent Psychiatry. 23(7). 587–598. 106 indexed citations

19.

Tu, Hong, Robin de Vries, Herman J. Woerdenbag, et al.. (2012). Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making. Value in Health Regional Issues. 1(1). 7–14. 14 indexed citations

20.

Zsarnovszky, Attila, Hoa H. Le, Hongsheng Wang, & Scott M. Belcher. (2005). Ontogeny of Rapid Estrogen-Mediated Extracellular Signal-Regulated Kinase Signaling in the Rat Cerebellar Cortex: Potent Nongenomic Agonist and Endocrine Disrupting Activity of the Xenoestrogen Bisphenol A. Endocrinology. 146(12). 5388–5396. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact